Am J Psychiatry 158:377-382, March 2001
© 2001 American Psychiatric Association
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Nora D. Volkow, M.D.,
Linda Chang, M.D.,
Gene-Jack Wang, M.D.,
Joanna S. Fowler, Ph.D.,
Maria Leonido-Yee, M.D.,
Dinko Franceschi, M.D.,
Mark J. Sedler, M.D.,
S. John Gatley, Ph.D.,
Robert Hitzemann, Ph.D.,
Yu-Shin Ding, Ph.D.,
Jean Logan, Ph.D.,
Christopher Wong, M.S., and
Eric N. Miller, Ph.D.
OBJECTIVE: Methamphetamine is a popular and highly addictive drug of abuse that has raised concerns because it has been shown in laboratory animals to be neurotoxic to dopamine terminals. The authors evaluated if similar changes occur in humans and assessed if they were functionally significant. METHOD: Positron emission tomography scans following administration of [11C]d-threo-methylphenidate (a dopamine transporter ligand) measured dopamine transporter levels (a marker of dopamine cell terminals) in the brains of 15 detoxified methamphetamine abusers and 18 comparison subjects. Neuropsychological tests were also performed to assess motor and cognitive function. RESULTS: Methamphetamine abusers showed significant dopamine transporter reduction in the striatum (mean differences of 27.8% in the caudate and 21.1% in the putamen) relative to the comparison subjects; this reduction was evident even in abusers who had been detoxified for at least 11 months. Dopamine transporter reduction was associated with motor slowing and memory impairment. CONCLUSIONS: These results provide evidence that methamphetamine at dose levels taken by human abusers of the drug leads to dopamine transporter reduction that is associated with motor and cognitive impairment. These results emphasize the urgency of alerting clinicians and the public of the long-term changes that methamphetamine can induce in the human brain.
This article has been cited by other articles:
|
|
|
|
 
E. R. Sowell, A. D. Leow, S. Y. Bookheimer, L. M. Smith, M. J. O'Connor, E. Kan, C. Rosso, S. Houston, I. D. Dinov, and P. M. Thompson
Differentiating Prenatal Exposure to Methamphetamine and Alcohol versus Alcohol and Not Methamphetamine using Tensor-Based Brain Morphometry and Discriminant Analysis
J. Neurosci.,
March 17, 2010;
30(11):
3876 - 3885.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Kalechstein, R. De La Garza II, T. F. Newton, M. F. Green, I. A. Cook, and A. F. Leuchter
Quantitative EEG Abnormalities are Associated With Memory Impairment in Recently Abstinent Methamphetamine-Dependent Individuals
J Neuropsychiatry Clin Neurosci,
August 1, 2009;
21(3):
254 - 258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Boileau, P. Rusjan, S. Houle, D. Wilkins, J. Tong, P. Selby, M. Guttman, J. A. Saint-Cyr, A. A. Wilson, and S. J. Kish
Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker?
J. Neurosci.,
September 24, 2008;
28(39):
9850 - 9856.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Sekine, Y. Ouchi, G. Sugihara, N. Takei, E. Yoshikawa, K. Nakamura, Y. Iwata, K. J. Tsuchiya, S. Suda, K. Suzuki, et al.
Methamphetamine Causes Microglial Activation in the Brains of Human Abusers
J. Neurosci.,
May 28, 2008;
28(22):
5756 - 5761.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Fowler, C. Kroll, R. Ferrieri, D. Alexoff, J. Logan, S. L. Dewey, W. Schiffer, D. Schlyer, P. Carter, P. King, et al.
PET Studies of d-Methamphetamine Pharmacokinetics in Primates: Comparison with l-Methamphetamine and ( )-Cocaine
J. Nucl. Med.,
October 1, 2007;
48(10):
1724 - 1732.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. A. Boger, L. D. Middaugh, K. S. Patrick, S. Ramamoorthy, E. D. Denehy, H. Zhu, A. M. Pacchioni, A.-C. Granholm, and J. F. McGinty
Long-Term Consequences of Methamphetamine Exposure in Young Adults Are Exacerbated in Glial Cell Line-Derived Neurotrophic Factor Heterozygous Mice
J. Neurosci.,
August 15, 2007;
27(33):
8816 - 8825.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Kalechstein, T. Fong, R. J. Rosenthal, A. Davis, H. Vanyo, and T. F. Newton
Pathological Gamblers Demonstrate Frontal Lobe Impairment Consistent With That of Methamphetamine-Dependent Individuals
J Neuropsychiatry Clin Neurosci,
August 1, 2007;
19(3):
298 - 303.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Advokat
Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD
J Atten Disord,
July 1, 2007;
11(1):
8 - 16.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Matsuzawa, K. Hashimoto, R. Miyatake, Y. Shirayama, E. Shimizu, K. Maeda, Y. Suzuki, Y. Mashimo, Y. Sekine, T. Inada, et al.
Identification of Functional Polymorphisms in the Promoter Region of the Human PICK1 Gene and Their Association With Methamphetamine Psychosis
Am J Psychiatry,
July 1, 2007;
164(7):
1105 - 1114.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Ito, K. Takuma, H. Mizoguchi, T. Nagai, and K. Yamada
A Novel Azaindolizinone Derivative ZSET1446 (Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one) Improves Methamphetamine-Induced Impairment of Recognition Memory in Mice by Activating Extracellular Signal-Regulated Kinase 1/2
J. Pharmacol. Exp. Ther.,
February 1, 2007;
320(2):
819 - 827.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Jeng, A. Ramkissoon, T. Parman, and P. G. Wells
Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration
FASEB J,
April 1, 2006;
20(6):
638 - 650.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Gouzoulis-Mayfrank and J. Daumann
The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview
J Psychopharmacol,
March 1, 2006;
20(2):
188 - 193.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. Yuan, G. Hatzidimitriou, P. Suthar, M. Mueller, U. McCann, and G. Ricaurte
Relationship between Temperature, Dopaminergic Neurotoxicity, and Plasma Drug Concentrations in Methamphetamine-Treated Squirrel Monkeys
J. Pharmacol. Exp. Ther.,
March 1, 2006;
316(3):
1210 - 1218.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Sekine, Y. Ouchi, N. Takei, E. Yoshikawa, K. Nakamura, M. Futatsubashi, H. Okada, Y. Minabe, K. Suzuki, Y. Iwata, et al.
Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers
Arch Gen Psychiatry,
January 1, 2006;
63(1):
90 - 100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. L. Jernigan, A. C. Gamst, S. L. Archibald, C. Fennema-Notestine, M. R. Mindt, T. L. Marcotte, R. K. Heaton, R. J. Ellis, and I. Grant
Effects of Methamphetamine Dependence and HIV Infection on Cerebral Morphology
Am J Psychiatry,
August 1, 2005;
162(8):
1461 - 1472.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ghaziani and T. D. Cook
Reducing HIV Infections at Circuit Parties: From Description to Explanation and Principles of Intervention Design
J Int Assoc Physicians AIDS Care (Chic Ill),
April 1, 2005;
4(2):
32 - 46.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T. E. Nordahl, R. Salo, Y. Natsuaki, G. P. Galloway, C. Waters, C. D. Moore, S. Kile, and M. H. Buonocore
Methamphetamine Users in Sustained Abstinence: A Proton Magnetic Resonance Spectroscopy Study
Arch Gen Psychiatry,
April 1, 2005;
62(4):
444 - 452.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Chang, T. Ernst, O. Speck, and C. S. Grob
Additive Effects of HIV and Chronic Methamphetamine Use on Brain Metabolite Abnormalities
Am J Psychiatry,
February 1, 2005;
162(2):
361 - 369.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Jayanthi, X. Deng, B. Ladenheim, M. T. McCoy, A. Cluster, N.-s. Cai, and J. L. Cadet
Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis
PNAS,
January 18, 2005;
102(3):
868 - 873.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.-J. Wang, L. Chang, N. D. Volkow, F. Telang, J. Logan, T. Ernst, and J. S. Fowler
Decreased brain dopaminergic transporters in HIV-associated dementia patients
Brain,
November 1, 2004;
127(11):
2452 - 2458.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Thomas, P. D. Walker, J. A. Benjamins, T. J. Geddes, and D. M. Kuhn
Methamphetamine Neurotoxicity in Dopamine Nerve Endings of the Striatum Is Associated with Microglial Activation
J. Pharmacol. Exp. Ther.,
October 1, 2004;
311(1):
1 - 7.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Thompson, K. M. Hayashi, S. L. Simon, J. A. Geaga, M. S. Hong, Y. Sui, J. Y. Lee, A. W. Toga, W. Ling, and E. D. London
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
J. Neurosci.,
June 30, 2004;
24(26):
6028 - 6036.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.-J. Wang, N. D. Volkow, L. Chang, E. Miller, M. Sedler, R. Hitzemann, W. Zhu, J. Logan, Y. Ma, and J. S. Fowler
Partial Recovery of Brain Metabolism in Methamphetamine Abusers After Protracted Abstinence
Am J Psychiatry,
February 1, 2004;
161(2):
242 - 248.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. D. London, S. L. Simon, S. M. Berman, M. A. Mandelkern, A. M. Lichtman, J. Bramen, A. K. Shinn, K. Miotto, J. Learn, Y. Dong, et al.
Mood Disturbances and Regional Cerebral Metabolic Abnormalities in Recently Abstinent Methamphetamine Abusers
Arch Gen Psychiatry,
January 1, 2004;
61(1):
73 - 84.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. CADET, S. JAYANTHI, and X. DENG
Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis
FASEB J,
October 1, 2003;
17(13):
1775 - 1788.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Sekine, Y. Minabe, Y. Ouchi, N. Takei, M. Iyo, K. Nakamura, K. Suzuki, H. Tsukada, H. Okada, E. Yoshikawa, et al.
Association of Dopamine Transporter Loss in the Orbitofrontal and Dorsolateral Prefrontal Cortices With Methamphetamine-Related Psychiatric Symptoms
Am J Psychiatry,
September 1, 2003;
160(9):
1699 - 1701.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. E. Nordahl, R. Salo, and M. Leamon
Neuropsychological Effects of Chronic Methamphetamine Use on Neurotransmitters and Cognition: A Review
J Neuropsychiatry Clin Neurosci,
August 1, 2003;
15(3):
317 - 325.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Kalechstein, T. F. Newton, and M. Green
Methamphetamine Dependence Is Associated With Neurocognitive Impairment in the Initial Phases of Abstinence
J Neuropsychiatry Clin Neurosci,
May 1, 2003;
15(2):
215 - 220.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A R Lingford-Hughes, S J C Davies, S McIver, T M Williams, M R C Daglish, and D J Nutt
Addiction: Imaging in clinical neuroscience
Br. Med. Bull.,
March 1, 2003;
65(1):
209 - 222.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Z. Goldstein and N. D. Volkow
Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
Am J Psychiatry,
October 1, 2002;
159(10):
1642 - 1652.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Jayanthi, M. T. McCoy, B. Ladenheim, and J. L. Cadet
Methamphetamine Causes Coordinate Regulation of Src, Cas, Crk, and the Jun N-Terminal Kinase-Jun Pathway
Mol. Pharmacol.,
May 1, 2002;
61(5):
1124 - 1131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Vinklerova, J. Novakova, and A. Sulcova
Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251
J Psychopharmacol,
March 1, 2002;
16(2):
139 - 143.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. D. Volkow, L. Chang, G.-J. Wang, J. S. Fowler, D. Franceschi, M. Sedler, S. J. Gatley, E. Miller, R. Hitzemann, Y.-S. Ding, et al.
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
J. Neurosci.,
December 1, 2001;
21(23):
9414 - 9418.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. D. Volkow
Drug Abuse and Mental Illness: Progress in Understanding Comorbidity
Am J Psychiatry,
August 1, 2001;
158(8):
1181 - 1183.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.M. Smith, L. Chang, M.L. Yonekura, C. Grob, D. Osborn, and T. Ernst
Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero
Neurology,
July 24, 2001;
57(2):
255 - 260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
This Is Your Brain -- Off Methamphetamines
Journal Watch Psychiatry,
March 22, 2001;
2001(322):
2 - 2.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2001
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
